Zobrazeno 1 - 6
of 6
pro vyhledávání: '"NANAE MASUNAGA"'
Autor:
Sakina Hashizume, Masafumi Shimoda, Tetsuhiro Yoshinami, Kaori Abe, Nanae Masunaga, Yoshiaki Sota, Tomohiro Miyake, Tomonori Tanei, Kenzo Shimazu
Publikováno v:
Surgical Case Reports, Vol 8, Iss 1, Pp 1-6 (2022)
Abstract Background Since humoral hypercalcemia of malignancy (HHM) in breast cancer patients without bone metastasis is rare, the clinical features of this condition are not fully understood. Case presentation During the recent 12 years, 3602 patien
Externí odkaz:
https://doaj.org/article/99f8a25b55544e639cc9a37f0bfcc515
Autor:
Nanae Masunaga, Naofumi Kagara, Daisuke Motooka, Shota Nakamura, Tomohiro Miyake, Tomonori Tanei, Yasuto Naoi, Masafumi Shimoda, Kenzo Shimazu, Seung Jin Kim, Shinzaburo Noguchi
Publikováno v:
Translational Oncology, Vol 13, Iss 3, Pp - (2020)
ESR1 mutations in breast cancer are known as one of the mechanisms of resistance to aromatase inhibitors. These mutations often occur in the hotspot regions in the ligand binding domain (LBD), but comprehensive mutational analysis has shown that muta
Externí odkaz:
https://doaj.org/article/c60697c0f285477e86862e639d71fd03
Autor:
SUNG AE PARK1, NANAE MASUNAGA1 nanae.masunaga@onsurg.med.osaka-u.ac.jp, NAOFUMI KAGARA2, YASUYO OHI3, NAOMI GONDO3, KAORI ABE1, TETSUHIRO YOSHINAMI1, YOSHIAKI SOTA1, TOMOHIRO MIYAKE1, TOMONORI TANEI1, MASAFUMI SHIMODA1, YASUAKI SAGARA3, KENZO SHIMAZU1
Publikováno v:
Oncology Letters. Nov2023, Vol. 26 Issue 5, p1-7. 7p.
Autor:
Yoko Hashimoto, Nanae Masunaga, Naofumi Kagara, Kaori Abe, Tetsuhiro Yoshinami, Masami Tsukabe, Yoshiaki Sota, Tomohiro Miyake, Tomonori Tanei, Masafumi Shimoda, Kenzo Shimazu
Publikováno v:
Cancers; Volume 15; Issue 9; Pages: 2632
ESR1 mutations in breast cancer are one of the mechanisms of resistance to aromatase inhibitors. These mutations are common in metastatic breast cancer; however, these are rare in primary breast cancer. However, these data have been analyzed mainly i
Autor:
Kenzo Shimazu, Shota Nakamura, Tomonori Tanei, Yasuto Naoi, Seung Jin Kim, Masafumi Shimoda, Daisuke Motooka, Tomohiro Miyake, Shinzaburo Noguchi, Nanae Masunaga, Naofumi Kagara
Publikováno v:
Breast Cancer Research and Treatment. 167:49-58
We aimed to develop a highly sensitive method to detect ESR1 mutations in cell-free DNA (cfDNA) using next-generation sequencing with molecular barcode (MB–NGS) targeting the hotspot segment (c.1600–1713). The sensitivity of MB–NGS was tested u
Autor:
Yasuto Naoi, Masafumi Shimoda, Seung Jin Kim, Kenzo Shimazu, Tomohiro Miyake, Shota Nakamura, Nanae Masunaga, Daisuke Motooka, Tomonori Tanei, Shinzaburo Noguchi, Naofumi Kagara
Publikováno v:
Translational Oncology
Translational Oncology, Vol 13, Iss 3, Pp-(2020)
Translational Oncology, Vol 13, Iss 3, Pp-(2020)
ESR1 mutations in breast cancer are known as one of the mechanisms of resistance to aromatase inhibitors. These mutations often occur in the hotspot regions in the ligand binding domain (LBD), but comprehensive mutational analysis has shown that muta